<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31532189</PMID><DateCompleted><Year>2020</Year><Month>07</Month><Day>08</Day></DateCompleted><DateRevised><Year>2021</Year><Month>04</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2373-8227</ISSN><JournalIssue CitedMedium="Internet"><Volume>5</Volume><Issue>11</Issue><PubDate><Year>2019</Year><Month>Nov</Month><Day>08</Day></PubDate></JournalIssue><Title>ACS infectious diseases</Title><ISOAbbreviation>ACS Infect Dis</ISOAbbreviation></Journal><ArticleTitle>A Novel Capsid Binding Inhibitor Displays Potent Antiviral Activity against Enterovirus D68.</ArticleTitle><Pagination><StartPage>1952</StartPage><EndPage>1962</EndPage><MedlinePgn>1952-1962</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1021/acsinfecdis.9b00284</ELocationID><Abstract><AbstractText>Enterovirus D68 (EV-D68) is a respiratory viral pathogen that primarily infects children under the age of 8. Although EV-D68 infection typically leads to moderate to severe respiratory illnesses, recent years have seen increasing cases of EV-D68 triggered neurological complications such as acute flaccid myelitis (AFM). There is currently no vaccine or antiviral available for EV-D68; we therefore aimed to develop potent and specific small molecule antivirals against EV-D68. In this study, we report our discovery of a viral capsid inhibitor <b>R856932</b> that inhibits multiple contemporary EV-D68 strains with single-digit to submicromolar efficacy. Mechanistic studies have shown that the tetrazole compound <b>R856932</b> binds to the hydrophobic pocket of viral capsid protein VP1, thereby preventing viral uncoating and release of viral genome in the infected cells. The mechanism of action of <b>R856932</b> was confirmed by time-of-addition, Western blot, RT-qPCR, viral heat inactivation, serial viral passage, and reverse genetics experiments. A single mutation located at VP1, A129V, confers resistance against <b>R856932</b>. However, a recombination virus encoding VP1-A129V appeared to have compromised fitness of replication compared to the wild-type EV-D68 virus as shown by the competition growth assay. Overall, the hit compound identified in this study, <b>R856932</b>, represents a promising starting point with a confirmed mechanism of action that can be further developed into EV-D68 antivirals.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Chunlong</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Pharmacology and Toxicology, College of Pharmacy , The University of Arizona , 1657 East Helen Street , Tucson , Arizona 85721 , United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Yanmei</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Pharmacology and Toxicology, College of Pharmacy , The University of Arizona , 1657 East Helen Street , Tucson , Arizona 85721 , United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Jiantao</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Pharmacology and Toxicology, College of Pharmacy , The University of Arizona , 1657 East Helen Street , Tucson , Arizona 85721 , United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Musharrafieh</LastName><ForeName>Rami</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Pharmacology and Toxicology, College of Pharmacy , The University of Arizona , 1657 East Helen Street , Tucson , Arizona 85721 , United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Jun</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-4845-4621</Identifier><AffiliationInfo><Affiliation>Department of Pharmacology and Toxicology, College of Pharmacy , The University of Arizona , 1657 East Helen Street , Tucson , Arizona 85721 , United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R33 AI119187</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 AI119187</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI157046</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI147325</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 AI144887</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>09</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>ACS Infect Dis</MedlineTA><NlmUniqueID>101654580</NlmUniqueID><ISSNLinking>2373-8227</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D013777">Tetrazoles</NameOfSubstance></Chemical><Chemical><RegistryNumber>288-94-8</RegistryNumber><NameOfSubstance UI="C045574">1H-tetrazole</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002213" MajorTopicYN="N">Capsid</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D030016" MajorTopicYN="N">Enterovirus D, Human</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062105" MajorTopicYN="N">Molecular Docking Simulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013777" MajorTopicYN="N">Tetrazoles</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053585" MajorTopicYN="N">Virus Attachment</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">EV-D68</Keyword><Keyword MajorTopicYN="N">antiviral</Keyword><Keyword MajorTopicYN="N">capsid inhibitor</Keyword><Keyword MajorTopicYN="N">enterovirus</Keyword><Keyword MajorTopicYN="N">pleconaril</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>9</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>7</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>9</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>4</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31532189</ArticleId><ArticleId IdType="mid">NIHMS1067066</ArticleId><ArticleId IdType="pmc">PMC7167248</ArticleId><ArticleId IdType="doi">10.1021/acsinfecdis.9b00284</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cassidy H; Poelman R; Knoester M; Van Leer-Buter CC; Niesters HGM Enterovirus D68-The New Polio? Front Microbiol 2018, 9, 2677.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6243117</ArticleId><ArticleId IdType="pubmed">30483226</ArticleId></ArticleIdList></Reference><Reference><Citation>Baggen J; Thibaut HJ; Strating JRPM; van Kuppeveld FJM The life cycle of non-polio enteroviruses and how to target it. Nat Rev Microbiol 2018, 16, 368&#x2013;381.</Citation><ArticleIdList><ArticleId IdType="pubmed">29626210</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun J; Hu XY; Yu XF Current Understanding of Human Enterovirus D68. Viruses 2019, 11, E490.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6631698</ArticleId><ArticleId IdType="pubmed">31146373</ArticleId></ArticleIdList></Reference><Reference><Citation>Lugo D; Krogstad P Enteroviruses in the early 21st century: new manifestations and challenges. Curr Opin Pediatr 2016, 28, 107&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4750492</ArticleId><ArticleId IdType="pubmed">26709690</ArticleId></ArticleIdList></Reference><Reference><Citation>Royston L; Essaidi-Laziosi M; Perez-Rodriguez FJ; Piuz I; Geiser J; Krause KH; Huang S; Constant S; Kaiser L; Garcin D; Tapparel C Viral chimeras decrypt the role of enterovirus capsid proteins in viral tropism, acid sensitivity and optimal growth temperature. PLoS Pathog 2018, 14, e1006962.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5908207</ArticleId><ArticleId IdType="pubmed">29630666</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y; Sheng J; van Vliet ALW; Buda G; van Kuppeveld FJM; Rossmann MG Molecular basis for the acid-initiated uncoating of human enterovirus D68. Proc Natl Acad Sci U S A 2018, 115, E12209&#x2013;E12217.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6310856</ArticleId><ArticleId IdType="pubmed">30530701</ArticleId></ArticleIdList></Reference><Reference><Citation>Oermann CM; Schuster JE; Conners GP; Newland JG; Selvarangan R; Jackson MA Enterovirus d68. A focused review and clinical highlights from the 2014 U.S. Outbreak. Ann Am Thorac Soc 2015, 12, 775&#x2013;781.</Citation><ArticleIdList><ArticleId IdType="pubmed">25714788</ArticleId></ArticleIdList></Reference><Reference><Citation>Dyda A; Stelzer-Braid S; Adam D; Chughtai AA; MacIntyre CR The association between acute flaccid myelitis (AFM) and Enterovirus D68 (EV-D68) - what is the evidence for causation? Eurosurveillance 2018, 23, 16&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5792700</ArticleId><ArticleId IdType="pubmed">29386095</ArticleId></ArticleIdList></Reference><Reference><Citation>Morens DM; Folkers GK; Fauci AS Acute Flaccid Myelitis: Something Old and Something New. Mbio 2019, 10, e00521&#x2013;19</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6445942</ArticleId><ArticleId IdType="pubmed">30940708</ArticleId></ArticleIdList></Reference><Reference><Citation>Messacar K; Schreiner TL; Van Haren K; Yang M; Glaser CA; Tyler KL; Dominguez SR Acute flaccid myelitis: A clinical review of US cases 2012&#x2013;2015. Ann Neurol 2016, 80, 326&#x2013;338.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5098271</ArticleId><ArticleId IdType="pubmed">27422805</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown DM; Hixon AM; Oldfield LM; Zhang Y; Novotny M; Wang W; Das SR; Shabman RS; Tyler KL; Scheuermann RH Contemporary Circulating Enterovirus D68 Strains Have Acquired the Capacity for Viral Entry and Replication in Human Neuronal Cells. mBio 2018, 9, e01954&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6191546</ArticleId><ArticleId IdType="pubmed">30327438</ArticleId></ArticleIdList></Reference><Reference><Citation>Midgley CM; Watson JT; Nix WA; Curns AT; Rogers SL; Brown BA; Conover C; Dominguez SR; Feikin DR; Gray S; Hassan F; Hoferka S; Jackson MA; Johnson D; Leshem E; Miller L; Nichols JB; Nyquist AC; Obringer E; Patel A; Patel M; Rha B; Schneider E; Schuster JE; Selvarangan R; Seward JF; Turabelidze G; Oberste MS; Pallansch MA; Gerber SI; Group E-DW Severe respiratory illness associated with a nationwide outbreak of enterovirus D68 in the USA (2014): a descriptive epidemiological investigation. Lancet Respir Med 2015, 3, 879&#x2013;887.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5693332</ArticleId><ArticleId IdType="pubmed">26482320</ArticleId></ArticleIdList></Reference><Reference><Citation>Greninger AL; Naccache SN; Messacar K; Clayton A; Yu G; Somasekar S; Federman S; Stryke D; Anderson C; Yagi S; Messenger S; Wadford D; Xia D; Watt JP; Van Haren K; Dominguez SR; Glaser C; Aldrovandi G; Chiu CY A novel outbreak enterovirus D68 strain associated with acute flaccid myelitis cases in the USA (2012&#x2013;14): a retrospective cohort study. Lancet Infect Dis 2015, 15, 671&#x2013;682.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6027625</ArticleId><ArticleId IdType="pubmed">25837569</ArticleId></ArticleIdList></Reference><Reference><Citation>Christy A; Messacar K Acute Flaccid Myelitis Associated With Enterovirus D68: A Review. J Child Neurol 2019, 34, 511&#x2013;516.</Citation><ArticleIdList><ArticleId IdType="pubmed">31014167</ArticleId></ArticleIdList></Reference><Reference><Citation>Hixon AM; Yu G; Leser JS; Yagi S; Clarke P; Chiu CY; Tyler KL A mouse model of paralytic myelitis caused by enterovirus D68. PLoS Pathog 2017, 13, e1006199.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5322875</ArticleId><ArticleId IdType="pubmed">28231269</ArticleId></ArticleIdList></Reference><Reference><Citation>Hurst BL; Evans WJ; Smee DF; Van Wettere A; Tarbet EB Evaluation of antiviral therapies in respiratory and neurological disease models of Enterovirus D68 infection in mice. Virology 2019, 526, 146&#x2013;154.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6309259</ArticleId><ArticleId IdType="pubmed">30390563</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrey JD; Wang H; Hurst BL; Zukor K; Siddharthan V; Van Wettere AJ; Sinex DG; Tarbet EB Causation of Acute Flaccid Paralysis by Myelitis and Myositis in Enterovirus-D68 Infected Mice Deficient in Interferon/Receptor Deficient Mice. Viruses 2018, 10, E33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5795446</ArticleId><ArticleId IdType="pubmed">29329211</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowers JR; Valentine M; Harrison V; Fofanov VY; Gillece J; Delisle J; Patton B; Schupp J; Sheridan K; Lemmer D; Ostdiek S; Bains HK; Heim J; Sylvester T; Prasai S; Kretschmer M; Fowle N; Komatsu K; Brady S; Robinson S; Fitzpatrick K; Ostovar GA; Alsop E; Hutchins E; Jensen K; Keim P; Engelthaler DM Genomic Analyses of Acute Flaccid Myelitis Cases among a Cluster in Arizona Provide Further Evidence of Enterovirus D68 Role. MBio 2019, 10, e02262&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6343034</ArticleId><ArticleId IdType="pubmed">30670612</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun L; Meijer A; Froeyen M; Zhang LL; Thibaut HJ; Baggen J; George S; Vernachio J; Kuppeveld FJM; Leyssen P; Hilgenfeld R; Neyts J; Delang L Antiviral Activity of Broad-Spectrum and Enterovirus-Specific Inhibitors against Clinical Isolates of Enterovirus D68. Antimicrob Agents Chemother 2015, 59, 7782&#x2013;7785.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4649165</ArticleId><ArticleId IdType="pubmed">26369972</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhoden E; Zhang M; Nix WA; Oberste MS In Vitro Efficacy of Antiviral Compounds against Enterovirus D68. Antimicrob Agents Chemother 2015, 59, 7779&#x2013;7781.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4649146</ArticleId><ArticleId IdType="pubmed">26149998</ArticleId></ArticleIdList></Reference><Reference><Citation>Smee DF; Evans WJ; Nicolaou KC; Tarbet EB; Day CW Susceptibilities of enterovirus D68, enterovirus 71, and rhinovirus 87 strains to various antiviral compounds. Antiviral Res 2016, 131, 61&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5100981</ArticleId><ArticleId IdType="pubmed">27063860</ArticleId></ArticleIdList></Reference><Reference><Citation>Messacar K; Sillau S; Hopkins SE; Otten C; Wilson-Murphy M; Wong B; Santoro JD; Treister A; Bains HK; Torres A; Zabrocki L; Glanternik JR; Hurst AL; Martin JA; Schreiner T; Makhani N; DeBiasi RL; Kruer MC; Tremoulet AH; Van Haren K; Desai J; Benson LA; Gorman MP; Abzug MJ; Tyler KL; Dominguez SR Safety, tolerability, and efficacy of fluoxetine as an antiviral for acute flaccid myelitis. Neurology 2019, 92, e2118&#x2013;e2126.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6512883</ArticleId><ArticleId IdType="pubmed">30413631</ArticleId></ArticleIdList></Reference><Reference><Citation>Musharrafieh R; Ma C; Zhang J; Hu Y; Diesing JM; Marty MT; Wang J Validating Enterovirus D68&#x2013;2A(pro) as an Antiviral Drug Target and the Discovery of Telaprevir as a Potent D68&#x2013;2A(pro) Inhibitor. J Virol 2019, 93, e02221&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6430540</ArticleId><ArticleId IdType="pubmed">30674624</ArticleId></ArticleIdList></Reference><Reference><Citation>Musharrafieh R; Zhang JT; Tuohy P; Kitamura N; Bellampalli SS; Hu YM; Khanna R; Wang J Discovery of Quinoline Analogues as Potent Antivirals against Enterovirus D68 (EV-D68). J Med Chem 2019, 62, 4074&#x2013;4090.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8055447</ArticleId><ArticleId IdType="pubmed">30912944</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y; Sheng J; Fokine A; Meng G; Shin WH; Long F; Kuhn RJ; Kihara D; Rossmann MG Structure and inhibition of EV-D68, a virus that causes respiratory illness in children. Science 2015, 347, 71&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4307789</ArticleId><ArticleId IdType="pubmed">25554786</ArticleId></ArticleIdList></Reference><Reference><Citation>Egorova A; Ekins S; Schmidtke M; Makarov V Back to the future: Advances in development of broad-spectrum capsid-binding inhibitors of enteroviruses. Eur J Med Chem 2019, 178, 606&#x2013;622.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8194503</ArticleId><ArticleId IdType="pubmed">31226653</ArticleId></ArticleIdList></Reference><Reference><Citation>Smee DF; Evans WJ; Nicolaou KC; Tarbet EB; Day CW Susceptibilities of enterovirus D68, enterovirus 71, and rhinovirus 87 strains to various antiviral compounds. Antiviral Res 2016, 131, 61&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5100981</ArticleId><ArticleId IdType="pubmed">27063860</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu J; He YQ; Yi LN; Zan H; Kung HF; He ML Viral kinetics of Enterovirus 71 in human abdomyosarcoma cells. World J Gastroenterol 2011, 17, 4135&#x2013;4142.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3203367</ArticleId><ArticleId IdType="pubmed">22039330</ArticleId></ArticleIdList></Reference><Reference><Citation>Lacroix C; Laconi S; Angius F; Coluccia A; Silvestri R; Pompei R; Neyts J; Leyssen P In vitro characterisation of a pleconaril/pirodavir-like compound with potent activity against rhinoviruses. Virol J 2015, 12, 106.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4501209</ArticleId><ArticleId IdType="pubmed">26169596</ArticleId></ArticleIdList></Reference><Reference><Citation>Musharrafieh R; Ma CL; Wang J Profiling the in vitro drug-resistance mechanism of influenza A viruses towards the AM2-S31N proton channel blockers. Antiviral Res 2018, 153, 10&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5891360</ArticleId><ArticleId IdType="pubmed">29518414</ArticleId></ArticleIdList></Reference><Reference><Citation>Dyda A; Stelzer-Braid S; Adam D; Chughtai AA; MacIntyre CR The association between acute flaccid myelitis (AFM) and Enterovirus D68 (EV-D68) - what is the evidence for causation? Euro Surveill 2018, 23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5792700</ArticleId><ArticleId IdType="pubmed">29386095</ArticleId></ArticleIdList></Reference><Reference><Citation>Willyard C An unknown enemy: Drugs sought against EV-68 as paralysis link is explored. Nat Med 2015, 21, 419&#x2013;421.</Citation><ArticleIdList><ArticleId IdType="pubmed">25822590</ArticleId></ArticleIdList></Reference><Reference><Citation>Senior K FDA panel rejects common cold treatment. Lancet Infect Dis 2002, 2, 264.</Citation><ArticleIdList><ArticleId IdType="pubmed">12062983</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Y; Zhang J; Musharrafieh R; Hau R; Ma C; Wang J Chemical Genomics Approach Leads to the Identification of Hesperadin, an Aurora B Kinase Inhibitor, as a Broad-Spectrum Influenza Antiviral. Int J Mol Sci 2017, 18, E1929.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5618578</ArticleId><ArticleId IdType="pubmed">28885544</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Y; Zhang J; Musharrafieh RG; Ma C; Hau R; Wang J Discovery of dapivirine, a nonnucleoside HIV-1 reverse transcriptase inhibitor, as a broad-spectrum antiviral against both influenza A and B viruses. Antiviral Res 2017, 145, 103&#x2013;113.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5599177</ArticleId><ArticleId IdType="pubmed">28778830</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J; Hu Y; Foley C; Wang Y; Musharrafieh R; Xu S; Zhang Y; Ma C; Hulme C; Wang J Exploring Ugi-Azide Four-Component Reaction Products for Broad-Spectrum Influenza Antivirals with a High Genetic Barrier to Drug Resistance. Sci Rep 2018, 8, 4653.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5854701</ArticleId><ArticleId IdType="pubmed">29545578</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma C; Zhang J; Wang J Pharmacological Characterization of the Spectrum of Antiviral Activity and Genetic Barrier to Drug Resistance of M2-S31N Channel Blockers. Mol Pharmacol 2016, 90, 188&#x2013;198.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4998667</ArticleId><ArticleId IdType="pubmed">27385729</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan ML; Gao S; Zhou ZW; Zhang KK; Liu SH; Wang ZY; Wang T A reverse genetics system for enterovirus D68 using human RNA polymerase I. Virus Genes 2018, 54, 484&#x2013;492.</Citation><ArticleIdList><ArticleId IdType="pubmed">29777445</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeda M; Pekosz A; Shuck K; Pinto LH; Lamb RA Influenza A virus M-2 ion channel activity is essential for efficient replication in tissue culture. J Virol 2002, 76, 1391&#x2013;1399.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC135863</ArticleId><ArticleId IdType="pubmed">11773413</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>